We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Marketing Oversight: Who Should Be in Charge?
Drug Marketing Oversight: Who Should Be in Charge?
August 30, 2006
An Aug. 15 article in the Annals of Internal Medicine proposing that the FDA and other regulatory agencies must step up to stem the tide of what it calls unscrupulous drug marketing practices is bringing to the fore the question of who is in the best position to police the drug marketing system.